Company intelligence / Profile preview

Floy

Munich, Bavaria, Germanyen.floy.com ↗

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

Floy's AI solutions have demonstrated improved accuracy and efficiency for radiologists analyzing CT and MRI scans. Published studies show enhanced early detection rates for conditions such as intracranial aneurysms, spinal malignancies, and breast cancer. The technology is certified as a medical device under MDR standards.

Therapeutic areas: OncologyNeurology
Modalities: DeviceSoftwareNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

Works with over 170 radiology practices across Germany

Beyond the preview

Go deeper on Floy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Floy.

Explore the full profile